Tag: Roche

  • AKU and Roche, Pakistan’s joint efforts bring relief to cancer patients

    On September 30, 2024, the leadership and healthcare professionals of the Aga Khan University (AKU) came together to celebrate the generosity of Roche, Pakistan, in providing access to cancer care at AKU’s Hospital in Karachi.

    Since 2018, Roche Pakistan under its access programme, has provided medicines to patients at the Aga Khan University Hospital (AKUH), ensuring that financial barriers do not prevent individuals from receiving the treatments they need. This initiative has not only eased the burden of medical costs for many families but has also restored the hope and dignity of those fighting cancer.

    This six-year partnership between AKU and Roche has benefited over 1500 cancer patients treated at AKUH. What brings the two organisations together is their shared goal of making high-quality life-saving cancer treatments accessible to patients who can’t afford them.

    “The fight against cancer in Pakistan is one that is far bigger than any single institution. It’s one that demands that people and institutions across the country join hands and work together. And that is precisely what Roche and AKU are doing”, said AKU President, Dr Sulaiman Shahabuddin at the appreciation event.

    The Aga Khan University Hospital’s Patient Welfare Programme brings together individual and corporate donors like Roche, Pakistan to support patients from low-income backgrounds to access critical treatments for complex diseases such as cancer. Since 1986, the welfare programme has disbursed nearly 35 billion rupees in welfare support, helping millions of individuals from across Pakistan to benefit from quality healthcare services at AKUH.

    Ms Hafsa Shamsie, Managing Director, Roche, Pakistan lauded the joint efforts in improving patients’ journey as they battle cancer. “I see it as a utopian ideal partnership. Why? Because we provide standard-of-care medication, and Aga Khan University Hospital is a Centre of Excellence,” she said.

    “The in-kind support from Roche, Pakistan not only provides vital medicines but also instils hope in our patients during some of their darkest times”, said Ms Zahra Somani, Chief Advancement Officer, AKU. “We look forward to continuing our partnership to expand access to quality cancer care for the people of Pakistan.”

    Also Read: The Aga Khan University Hospital Rallies the Community for Heart Health

  • Rare Diseases Need Government Attention

    In recognition of Rare Disease Day, Roche Pakistan Limited held a panel discussion and press briefing to raise awareness about rare diseases in Pakistan and to emphasize the unmet needs of patients especially when it comes to awareness, funding, and government support. The panel comprised MD Roche Pakistan, Ms. Hafsa Shamsie, Roche’s Head of Medical, Dr. Yasir Adnan as well as paeds neurologist Dr. Raman Kumar and hematologist Dr. Munira Borhany and Dr. Saqib, Director Health, Services, Health Department, Govt. of Sindh.

    Ms. Hafsa Shamsie, MD Roche highlighted the fact that even for those who have been diagnosed, the lack of government healthcare spending and support makes the treatment burden for rare diseases even more difficult to bear. Rare disease sufferers are the neglected outliers in Pakistan’s healthcare system. Roche is a company that is committed to serving rare disease patients by bringing innovative treatments that can help patients live a fully normal life or at least a much better quality of life. But, treatment is one side of the picture. Ensuring that patients have awareness about rare diseases, and access to these standard-of-care treatments is the other side of the picture. She shared that since 2017, Roche has run a Patient Support Program that has helped almost 25,000 patients with free-of-cost treatment for several diseases including Spinal Muscular Atrophy and Multiple Sclerosis. But as the burden of disease grows no one company or entity can go it alone. That is why it is critical to have the government on board through public-private partnerships. This will help to support rare disease patients by including funding for standard-of-care treatments in government healthcare programs. She said rare disease patients deserve the same care, attention, and inclusion as other patients and that is why it is time that “Recognizing Rare” becomes a healthcare priority too.

    Dr. Yasir Adnan explained that worldwide about 300 million people live with a rare disease. Moreover, with Pakistan having over 240 million people, the rare disease incidence in this country becomes more acute with such a large population. Rare diseases like Multiple Sclerosis, Spinal Muscular Atrophy, and Hemophilia pose not only debilitating physical and health challenges for the sufferer but also grave challenges for the families of sufferers and the society at large. Without treatment, children are deprived of the chance for a normal life such as in the case of hemophilia, young women lose out on their most productive years as in the case of multiple sclerosis, and even SMA patients who could perhaps regain function are unable to do so. One of the other problems is that rare diseases can sometimes be invisible to others and it can take years sometimes for someone to even get a diagnosis. Worse still, these people are often lost within a healthcare system that fails to give them answers.

    He stated that worldwide, less than 10% of patients with rare diseases are treated. So the number of rare disease sufferers coming through the system is already an underrepresentation – especially in a country with poverty and low literacy. He talked about Multiple sclerosis (MS) – a condition that can affect the brain and spinal cord, causing a wide range of potential symptoms, including problems with vision, arm or leg movement, sensation, or balance. It’s a lifelong condition that can sometimes cause serious disability. It’s most commonly diagnosed in people in their 20s, 30s, and 40s although it can develop at any age. It’s about 2 to 3 times more common in women than men. MS is a disabling and stigmatizing disease that can lead to social isolation and exclusion. Governments, national healthcare systems, employers, and legislation must enable people with MS to achieve a quality of life. This includes diagnosing and treating the disease early to stave off relapses and prevent the progression of disability, alongside protective legislation to enable people to access affordable treatment as well as remain in employment.

    Dr. Raman Kumar said spinal muscular atrophy (SMA) is a severe neuromuscular disease and one of the leading genetic causes of infant death.  He said that even though there was a lack of data to assess the prevalence of SMA in Pakistan, cousin marriages are the most common reason attributed for its occurrence and Pakistan had a very high frequency of cousin marriages. Dr. Kumar suggested that Govt/the policymakers should work on establishing National/Provincial Policies for Rare Diseases and capacity building of healthcare infrastructure to serve rare disease patients. Further, he encouraged all relevant stakeholders to empower people living with SMA for equitable access to diagnosis, treatment care, and social opportunities.

    Dr. Munira Borhany explained that Hemophilia A is a debilitating and life-threatening bleeding disorder. Hemophilia A severely affects the quality of life of patients who may experience spontaneous bleeding and bleeding due to trauma within the muscles, joints, and other internal organs, often 15-20 times a year. These bleeding episodes may either end up being fatal or result in permanent joint disability. Hemophilia A, patients experience long-term psychosocial impacts as well. Children face barriers to socialization (missed school, unable to play with friends), leading to an impact on education and career decisions. Later in life, they face workplace issues (missed days at work), and have to constantly rely on carers to manage bleeds. She emphasized that in Pakistan there was a severe lack of hemophilia management infrastructure and was not generally treated in tertiary care hospitals. In addition, hemophilia standard-of-care treatment was generally not covered under any government health program. As a result, patients were forced to use conventional treatments, which hindered their chances to live normal lives. She said there is a dire need for our provincial governments to provide the utmost support, especially in terms of standard-of-care treatment, so that patients could live normal lives and become active members of society.

    Also Read: 35th ‘Vision Eye Camp’ held to Bring Sight and Hope to almost 600 patients in Lahore and Karachi